ALK-abello A/S Class B (AKBLF)
OTHER OTC:AKBLF
Comparison Results
Inovio Pharmaceuticals
$1.09
$86.85M
-9.60
-32.30%
1 Buy
1 Hold
0 Sell
Moderate Buy
Aclaris Therapeutics
$3.90
$487.20M
-4.66
239.13%
3 Buy
0 Hold
0 Sell
Strong Buy
Emergent Biosolutions
$8.24
$411.09M
12.57
87.70%
1 Buy
0 Hold
0 Sell
Moderate Buy
Novartis
$154.47
$283.71B
19.02
43.67%
3 Buy
3 Hold
0 Sell
Moderate Buy
Bristol-Myers Squibb
$58.06
$119.69B
15.61
14.49%
7 Buy
12 Hold
1 Sell
Moderate Buy
Performance Comparison
AKBLF
ALK-abello
33.25
11.67
54.06%
DVAX
―
―
―
―
INO
Inovio Pharmaceuticals
1.09
-0.68
-38.42%
ACRS
Aclaris Therapeutics
3.90
2.72
230.51%
EBS
Emergent Biosolutions
8.24
3.66
79.91%
NVS
Novartis
154.47
47.11
43.88%
BMY
Bristol-Myers Squibb
58.06
9.16
18.74%